Evidence map›Paper›PMID 33005723›Full record

ArticleAlzheimer's & dementia (Amsterdam, Netherlands)2020

Predicting amyloid status using self-report information from an online research and recruitment registry: The Brain Health Registry.

Miriam T Ashford, John Neuhaus, Chengshi Jin, Monica R Camacho, Juliet Fockler, Diana Truran, R Scott Mackin, Gil D Rabinovici, Michael W Weiner, Rachel L Nosheny

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's & dementia (Amsterdam, Netherlands), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Brain health registry updates: An online longitudinal neuroscience platform.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023
    Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Miriam T AshfordNorthern California Institute for Research and Education (NCIRE) Department of Veterans Affairs Medical Center San Francisco California USA.
John NeuhausDepartment of Epidemiology and Biostatistics University of California San Francisco San Francisco California USA.
Chengshi JinDepartment of Epidemiology and Biostatistics University of California San Francisco San Francisco California USA.
Monica R CamachoNorthern California Institute for Research and Education (NCIRE) Department of Veterans Affairs Medical Center San Francisco California USA.
Juliet FocklerDepartment of Veterans Affairs Medical Center Center for Imaging and Neurodegenerative Diseases San Francisco California USA.
Diana TruranNorthern California Institute for Research and Education (NCIRE) Department of Veterans Affairs Medical Center San Francisco California USA.
R Scott MackinDepartment of Veterans Affairs Medical Center Center for Imaging and Neurodegenerative Diseases San Francisco California USA.
Gil D RabinoviciDepartment of Radiology and Biomedical Imaging University of California San Francisco California USA.
Michael W WeinerNorthern California Institute for Research and Education (NCIRE) Department of Veterans Affairs Medical Center San Francisco California USA.
Rachel L NoshenyDepartment of Veterans Affairs Medical Center Center for Imaging and Neurodegenerative Diseases San Francisco California USA.
University of California, San Francisco · USSan Francisco VA Medical Center · USNorthern California Institute for Research and Education · USUniversity of California System · US

Funding

Project 1U19AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI MICHAEL W WEINER · 2016 to 2026
$226.7M
The Alzheimer's Clinical Trial Consortium - Down Syndrome Network (ACTC- DSN)U24AG057437 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Paul S. Aisen, RONALD C PETERSEN · 2018 to 2026
$198.4M
Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's DiseaseR01AG053798 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI AISEN, PAUL S., CUMMINGS, JEFFREY L. · 2017 to 2022
$39.4M
Democratising Machine Learning for researchers working in Alzheimer's spaceR01AG058676 · NIA · UNIVERSITY OF MELBOURNE · PI MASTERS, COLIN · 2018 to 2022
$10.9M
Characterizing Cognitive Decline in Late Life Depression: The ADNI-D ProjectR01MH098062 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Robert Scott Mackin · 2013 to 2026
$9.1M
Validation of Online Methods to Predict and Monitor Cognitive DeclineRF1AG059009 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NOSHENY, RACHEL LAUREN · 2018 to 2018
$6.2M
The Brain Health Registry for facilitating interdisciplinary aging researchR33AG062867 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NOSHENY, RACHEL LAUREN · 2020 to 2024
$3.2M
Implementation and validation of an online Caregiver and Study Partner Portal for assessment of cognitive function in older adultsK01AG055692 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NOSHENY, RACHEL LAUREN · 2017 to 2021
$719k
NIA NIH HHS K01 AG055692NIA NIH HHS R01 AG053798NIA NIH HHS R01 AG058676NIA NIH HHS R33 AG062867NIA NIH HHS RF1 AG059009NIA NIH HHS U19 AG024904NIA NIH HHS U24 AG057437NIMH NIH HHS R01 MH098062
6 · The paper itself

Abstract

introductionThis study aimed to predict brain amyloid beta (Aβ) status in older adults using collected information from an online registry focused on cognitive aging.

methodsAβ positron emission tomography (PET) was obtained from multiple in-clinic studies. Using logistic regression, we predicted Aβ using self-report variables collected in the Brain Health Registry in 634 participants, as well as a subsample (N = 533) identified as either cognitively unimpaired (CU) or mild cognitive impairment (MCI). Cross-validated area under the curve (cAUC) evaluated the predictive performance.

resultsThe best prediction model included age, sex, education, subjective memory concern, family history of Alzheimer's disease, Geriatric Depression Scale Short-Form, self-reported Everyday Cognition, and self-reported cognitive impairment. The cross-validated AUCs ranged from 0.62 to 0.66. This online model could help reduce between 15.2% and 23.7% of unnecessary Aβ PET scans in CU and MCI populations. DISUCSSION: The findings suggest that a novel, online approach could aid in Aβ prediction.

Indexed as

amyloidBrain Health Registrycognitively unimpaireddementiaIDEAS studyInternetmild cognitive impairmentpredictionresearch registryself‐report

Identifiers

PMID33005723
PMCPMC7513627
OpenAlexW3088127470

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.